Evolution of oculomotor and clinical findings in autopsy-proven richardson syndrome

A. Hardwick; J. C. Rucker; M. L. Cohen; R. P. Friedland; K. Gustaw-Rothenberg; D. E. Riley; R. J. Leigh

doi:10.1212/WNL.0b013e3181c67ba2

Evolution of oculomotor and clinical findings in autopsy-proven richardson syndrome

A. Hardwick, J. C. Rucker, M. L. Cohen, R. P. Friedland, K. Gustaw-Rothenberg, D. E. Riley, R. J. Leigh

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	2122-2124
Number of pages	3
Journal	Neurology
Volume	73
Issue number	24
DOIs	https://doi.org/10.1212/WNL.0b013e3181c67ba2
State	Published - Dec 2009
Externally published	Yes

Access to Document

10.1212/WNL.0b013e3181c67ba2

Cite this

@article{ea3ff9eaeb9044409fac813d60a6b57a,

title = "Evolution of oculomotor and clinical findings in autopsy-proven richardson syndrome",

author = "A. Hardwick and Rucker, \{J. C.\} and Cohen, \{M. L.\} and Friedland, \{R. P.\} and K. Gustaw-Rothenberg and Riley, \{D. E.\} and Leigh, \{R. J.\}",

note = "Funding Information: Disclosure: Dr. Hardwick reports no disclosures. Dr. Rucker serves as neuro-ophthalmology Section Editor of the British Journal of Ophthalmology and has received honoraria for lectures or educational activities not funded by industry. Dr. Cohen serves on the editorial board of the Open Pathology Journal; receives royalties from publishing Practical Differential Diagnosis in Surgical Neuropathology (Humana Press, 2000); and receives research support from the Centers for Disease Control [ RES502729 (Co-I) ] and the Alzheimer's Association [ZEN-06-27485 (Co-PI)]. Dr. Friedland received speaker honoraria from Pfizer Inc.; served as a consultant for MIMVista Corp.; and receives research support from the NIH [ R01-AG017173 (PI) ], the Joseph and Florence Mandel Research Fund, and the Nickman Family. Dr. Gustaw-Rothenberg reports no disclosures. Dr. Riley serves on the Medical Advisory Board of CurePSP; serves on speakers' bureaus for and/or received speaker honoraria from Allergan, Inc., GlaxoSmithKline, and Lundbeck Inc.; and has received research support from Allergan, Inc., SCHWARZ PHARMA, Medtronic, Inc., the NIH [R01 AG024040-03 (Investigator)], the National Center for Research Resources, Cleveland Medical Devices, and the Gift of Nina and Sandy McAfee. Dr. Leigh serves as a member of the NIH /National Eye Institute Central Visual Processing study section; receives royalties from coauthoring The Neurology of Eye Movements (Oxford University Press, 2006); and receives research support from the NIH [ NEI R01 EY06717 (PI) ], the Department of Veterans Affairs, the Office of Research and Development, Medical Research Service (Investigation and Treatment of Vestibulo-Visual Disorders, PI), and the Evenor Armington Fund. ",

year = "2009",

month = dec,

doi = "10.1212/WNL.0b013e3181c67ba2",

language = "English",

volume = "73",

pages = "2122--2124",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "24",

}

TY - JOUR

T1 - Evolution of oculomotor and clinical findings in autopsy-proven richardson syndrome

AU - Hardwick, A.

AU - Rucker, J. C.

AU - Cohen, M. L.

AU - Friedland, R. P.

AU - Gustaw-Rothenberg, K.

AU - Riley, D. E.

AU - Leigh, R. J.

N1 - Funding Information: Disclosure: Dr. Hardwick reports no disclosures. Dr. Rucker serves as neuro-ophthalmology Section Editor of the British Journal of Ophthalmology and has received honoraria for lectures or educational activities not funded by industry. Dr. Cohen serves on the editorial board of the Open Pathology Journal; receives royalties from publishing Practical Differential Diagnosis in Surgical Neuropathology (Humana Press, 2000); and receives research support from the Centers for Disease Control [ RES502729 (Co-I) ] and the Alzheimer's Association [ZEN-06-27485 (Co-PI)]. Dr. Friedland received speaker honoraria from Pfizer Inc.; served as a consultant for MIMVista Corp.; and receives research support from the NIH [ R01-AG017173 (PI) ], the Joseph and Florence Mandel Research Fund, and the Nickman Family. Dr. Gustaw-Rothenberg reports no disclosures. Dr. Riley serves on the Medical Advisory Board of CurePSP; serves on speakers' bureaus for and/or received speaker honoraria from Allergan, Inc., GlaxoSmithKline, and Lundbeck Inc.; and has received research support from Allergan, Inc., SCHWARZ PHARMA, Medtronic, Inc., the NIH [R01 AG024040-03 (Investigator)], the National Center for Research Resources, Cleveland Medical Devices, and the Gift of Nina and Sandy McAfee. Dr. Leigh serves as a member of the NIH /National Eye Institute Central Visual Processing study section; receives royalties from coauthoring The Neurology of Eye Movements (Oxford University Press, 2006); and receives research support from the NIH [ NEI R01 EY06717 (PI) ], the Department of Veterans Affairs, the Office of Research and Development, Medical Research Service (Investigation and Treatment of Vestibulo-Visual Disorders, PI), and the Evenor Armington Fund.

PY - 2009/12

Y1 - 2009/12

UR - https://www.scopus.com/pages/publications/73349135932

U2 - 10.1212/WNL.0b013e3181c67ba2

DO - 10.1212/WNL.0b013e3181c67ba2

M3 - Article

AN - SCOPUS:73349135932

SN - 0028-3878

VL - 73

SP - 2122

EP - 2124

JO - Neurology

JF - Neurology

IS - 24

ER -